Clinical trial
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney…
NCT00357760 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00357760 |
|---|---|
| Title | Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer |
| Official title | A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Metastatic Renal Cell Carcinoma |
| Intervention type | Biological |
| Interventions | VEGF Trap |
| Enrollment | 94 |
| Start date | Dec 1, 2007 |
| Primary completion | Oct 1, 2015 |
| Completion | Oct 1, 2015 |
| First posted | Jul 27, 2006 |
| Last update posted | Jun 23, 2017 |
| Countries | Peru, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: